
Obesity Studies Rotorua
Rotorua
Are you overweight or overweight with Type 2 Diabetes? Diet & exercise not working?
You might be able to join a clinical trial to help develop a potential weight loss treatment for people who are overweight or overweight with Type 2 Diabetes.
Eligible participants will continue their current diabetes medications throughout the study, and will receive:
Description
What to expect
Ages
Aged 18–65
Duration
51 visits over 58 weeks (no overnight stays)
Compensation
You will be reimbursed for your time and travel costs
Eligibility Criteria
A)
B)
Locations
Around 1 in 3 Kiwis are considered clinically obese, according to the NZ Health Survey 2020/2021. Obesity is a complex, long-term condition linked to factors like genetics, hormones, and environment - not just lifestyle. It increases the risk of serious health issues like heart disease, type 2 diabetes, and sleep apnoea, and can also affect mental wellbeing. That’s why researchers are working to find new treatment options to support healthy weight management. This study is testing a potential new treatment that is expected to work by activating a signal in the body that may potentially support healthy weight and sugar levels, without some of the side effects seen in other treatments.
Study duration: About 51 clinic visits over 58 weeks (NO overnight stays)
- You may receive either the investigational medication or a placebo
- Your personal info will be kept private
- There’s free parking and flexible appointments
- Medsafe and HDEC approval is required to run studies in New Zealand
Participating in studies will help researchers learn more about obesity and aid in the development of potential new treatments. Please fill out the form to register your interest. If you're eligible, our team will be in touch to guide you through the next steps. Let’s do something good together.
References
1 NZ Health Survey 2020/2021
2 To calculate your BMI, go to BMI Calculator
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.